Showing 9891-9900 of 18094 results for "".
- Biologics Linked to Lower Infection Risk in Older Psoriatic Patients: Studyhttps://reachmd.com/news/biologics-linked-to-lower-infection-risk-in-older-psoriatic-patients-study/2471809/Biologics targeting interleukin (IL)-12, IL-23, and IL-17 were associated with lower rates of serious infection in older adults with psoriatic disease, according to a cohort study using Ontario health data. The study, publishe
- Sniffing Out Early Signs: Olfactory Testing for Cognitive Impairment Detectionhttps://reachmd.com/news/sniffing-out-early-signs-olfactory-testing-for-cognitive-impairment-detection/2471803/Recent clinical research indicates that evaluating olfactory function through tests of odor discrimination, identification, and memory offers a non-invasive early marker for cognitive impairment. The Discovery: Olfactory Decline as a Biomarker<
- Unraveling Metabolic Mysteries: Blood-Derived Immune Cells and Dravet Syndromehttps://reachmd.com/news/unraveling-metabolic-mysteries-blood-derived-immune-cells-and-dravet-syndrome/2471800/Recent research from the University of Colorado Anschutz Medical Campus uncovers significant metabolic impairments in lymphoblast cell lines from children with Dravet syndrome, underscoring a vital connection between immune cell energy management and neurological function.<
- Harnessing Genetically Modified Natural Killer Cells to Revolutionize Cancer Immunotherapyhttps://reachmd.com/news/harnessing-genetically-modified-natural-killer-cells-to-revolutionize-cancer-immunotherapy/2471799/Recent advancements in oncology, genetics, and health technology are forging new paths in cancer therapy. Researchers are now transforming NK cells—vital components of the immune system—using CRISPR/Cas9 technology. These innovations empower cells to better identif
- Exploring Maternal ACEs, Perinatal Depression, and Infant Adversity: Unraveling Intergenerational Impactshttps://reachmd.com/news/exploring-maternal-aces-perinatal-depression-and-infant-adversity-unraveling-intergenerational-impacts/2471778/Recent evidence underscores the intricate links between maternal adverse childhood experiences, perinatal depression, and infant developmental challenges, highlighting the transformative potential of early interventions in disrupting intergenerational trauma.
- Tailoring Care to Combat Long-Term Mortality in Severely Injured Elderly Trauma Patientshttps://reachmd.com/news/tailoring-care-to-combat-long-term-mortality-in-severely-injured-elderly-trauma-patients/2471767/Enhancing Long-Term Survival with Targeted Interventions in Elderly Trauma Care Current research demonstrates that trauma patients over the age of 80 endure nearly double the 1-year mortality rate of younger populations. This notable differenc
- Advancing Breast Imaging: AI and BI-RADS Unite to Reduce Unnecessary Biopsieshttps://reachmd.com/news/advancing-breast-imaging-ai-and-bi-rads-unite-to-reduce-unnecessary-biopsies/2471786/The landscape of breast imaging is undergoing significant advancements through the integration of AI with BI-RADS, aiming to reduce non-essential benign biopsies. This innovative approach combines cutting-edge technology with traditional radiologic methods, enhancing diagno
- Evaluating the Safety and Efficacy of QX004N: A Novel Anti–IL-23 Biologic for Plaque Psoriasishttps://reachmd.com/news/evaluating-the-safety-and-efficacy-of-qx004n-a-novel-antiil-23-biologic-for-plaque-psoriasis/2471781/Recent clinical investigations have highlighted QX004N, an anti–IL-23 monoclonal antibody, as a promising therapy for moderate to severe plaque psoriasis. Emphasizing detailed safety evaluations, pharmacokinetic analysis, and marked clinical efficacy improvements, this stud
- Innovative Drug Combination Paves New Avenues in Melanoma Brain Metastasis Treatmenthttps://reachmd.com/news/innovative-drug-combination-paves-new-avenues-in-melanoma-brain-metastasis-treatment/2471776/A groundbreaking approach with a new pharmacological combination reveals encouraging results in treating and possibly preventing brain metastasis in melanoma patients. Initial observations highlight notable control over melanoma's progression to the brain, extending benefi
- Emrosi Officially Launched for Treatment of Inflammatory Rosaceahttps://reachmd.com/news/emrosi-officially-launched-for-treatment-of-inflammatory-rosacea/2471775/Journey Medical has announced the launch and initial prescriptions for Emrosi for the treatment of inflammatory lesions of rosacea in adults. According to a press release from the manufacturer, the minocycline hydrochloride modi